InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,731.33
(
-0.03%
)
US TECH 100
19,447.60
(
0.17%
)
Dow Jones
41,991.82
(
-0.51%
)
Brent Oil
73.51
(
-1.41%
)
Bitcoin
63,770.11
(
-0.78%
)
Post# of 403529
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

thefamilyman

Send PM Follow Ignore
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

thefamilyman

Re: sunspotter post# 375738

Friday, 09/24/2021 10:42:50 AM

Friday, September 24, 2021 10:42:50 AM

Post# of 403529
I can. Some patients are apparently having to discontinue Remdesivir because they are experiencing significant SAE’s. In some cases, those SAE’s may be being cited as one reason for needing approval for the compassionate use of Brilacidin.

Sunspotter said,

I don't know for sure, but I really can't imagine any doctor withdrawing SoC in the shape of either remdesivir or dexamethasone before administering brilacidin to a patient in extremis.

"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Start posting your company's news
Only $200 per official company press release!